retatrutide osteoarthritis (Eli Lilly's triple GLP-1/GIP/Glucagon receptor agonist) just delivered the most impressive obesity + data we've ever seen in the phase 3 TRIUMPH-4 trial: Lilly's triple agonist, retatrutide, delivered
Pay in 4 interest-free payments of $6.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13















:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)












